Skip to main content
SpringerLink
Log in

Comment on Elit et al.: Prophylactic oophorectomy in Ontario

  • Commentary
  • Published:
Familial Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lerman C, Daly M, Masny G, Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 1994; 12: 843-50.

    Google Scholar 

  2. Rose PG, Fusco N, Fluellen L, Rodriguez M. Tolerance of twenty-four hour paclitaxel and carboplatin as first-line therapy in ovarian, peritoneal and fallopian tube carcinoma. Int J Gynecol Cancer. 1999 Nov; 9(6): 448-51.

    Google Scholar 

  3. Agoff SN, Mendelin JE, Verena SG, Garcia RL. Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or-2 mutations. Am J Surg Pathol 2002; 26(2): 171-8.

    Google Scholar 

  4. Paley PJ, Swisher EM, Garcia RL et al. Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis. Gynecol Oncol 2001; 80: 176-80.

    Google Scholar 

  5. Zweemer RP, van Diest PJ, V erheijen RHM et al. Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations. Gynecol Oncol 2000; 76(1): 45-50.

    Google Scholar 

  6. Morice P, Pautier P, Mercier S et al. Laparoscopic prphylactic oophorectomies in women with inherited risk of ovarian cancer. Eur J Obstet Gyn 1999; 20: 202-4.

    Google Scholar 

  7. Kauff ND, Satagopan JM, Robson ME et al. Risk-reducing salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations. NEJM 2002; 346: 1609-15.

    Google Scholar 

  8. Woolas R, Jacobs I, Prys Davies A et al. What is the true incidence of fallopian tube carcinoma? Int J Gynaec Cancer 1996; 4: 348.

    Google Scholar 

  9. Narod SA, Brunet JS, Ghadirian P et al. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study, Hereditary Breast Cancer Clinical Study Group. Lancet 2000; 356: 1876-81.

    Google Scholar 

  10. Goshen R, Chu W, Elit L et al. Is uterine papillary serous adeno-carcinoma a menifestation of the hereditary breast-ovarian cancer syndrome? Gynecol Oncol 2000; 79(3): 477-81.

    Google Scholar 

  11. Moslehi R, Chu W, Karlan B et al. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer. Am J Hum Genet 2000; 66: 1259-72.

    Google Scholar 

  12. Wolmark N, Dunn BK. The role of tamoxifen in breast cancer prevention: issues sparked by the NSABP Breast Cancer Prevention Trial (P-1). Ann NY Acad Sci 2001; 949: 99-108.

    Google Scholar 

  13. Piver MS, Jishi MF, Tsukada Y, Nava G. Primary peritoneal carcinoma after prphylactic oophorectomy in women with a family history of ovarian cancer. Cancer 1993; 71: 2751-5.

    Google Scholar 

  14. Tobacman JK, Greene MH, Tucker MA et al. Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovariancancer-prone families. Lancet 1982; 2(8302): 795-7.

    Google Scholar 

  15. Piura B, Rabinovich A, Yanai-Inbar I. Three primary malignancies related to BRCA mutation successively occurring in a BRCA1 185delAG mutation carrier. Eur J Obstet Gynecol Reprod Biol 2001; 97: 241-4.

    Google Scholar 

  16. Ansink AC, Burger CW, Seynaeve C. Prophylactic surgery in patients with inherited risk of ovarian cancer (letter). Lancet 2001; 83: 445.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynaecology, VU Medical Center, P.O. Box 7057, 1007 MB, Amsterdam, the Netherlands

    R. P. Zweemer

  2. Department of Gynecological Oncology, St. Bartholomew's and the Royal London School of Medicine and Dentistry, London, UK

    I. J. Jacobs

Authors
  1. R. P. Zweemer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. J. Jacobs
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zweemer, R.P., Jacobs, I.J. Comment on Elit et al.: Prophylactic oophorectomy in Ontario. Familial Cancer 1, 187–188 (2001). https://doi.org/10.1023/A:1021125416622

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1021125416622

Search

Navigation